يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Glucagon-Like Peptide-1 Receptor"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice.

    المؤلفون: Wang, Vicki1,2 (AUTHOR), Tseng, Kuan-Yin3,4 (AUTHOR), Kuo, Tung-Tai3,5 (AUTHOR), Huang, Eagle Yi-Kung5 (AUTHOR), Lan, Kuo-Lun6 (AUTHOR), Chen, Zi-Rong6 (AUTHOR), Ma, Kuo-Hsing7 (AUTHOR), Greig, Nigel H.8 (AUTHOR), Jung, Jin9 (AUTHOR), Choi, Ho-II9 (AUTHOR), Olson, Lars10 (AUTHOR), Hoffer, Barry J.11 (AUTHOR), Chen, Yuan-Hao3,4 (AUTHOR) chenyh178@gmail.com

    المصدر: Journal of Biomedical Science. 4/17/2024, Vol. 31 Issue 1, p1-19. 19p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *MITOCHONDRIA, *PARKINSON'S disease, *TYROSINE hydroxylase, *CYTOCHROME c

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies.

    المؤلفون: Ahmad, Aftab1,2 (AUTHOR) draahmad@yahoo.com, Sabbour, Hani3,4,5 (AUTHOR)

    المصدر: Cardiovascular Diabetology. 3/18/2024, Vol. 23 Issue 1, p1-22. 22p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *CARRIER proteins, *TYPE 2 diabetes, *PROTEIN transport, *SYSTOLIC blood pressure

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway.

    المؤلفون: Kang, Xiaonan1 (AUTHOR), Wang, Dan1 (AUTHOR), Zhang, Lu1 (AUTHOR), Huang, Teng1 (AUTHOR), Liu, Siyue1 (AUTHOR), Feng, Xiaohui1 (AUTHOR), Guo, Yaoyao1 (AUTHOR), Zhang, Ziyin1 (AUTHOR), Wang, Zhongjing2 (AUTHOR) doctorwangzj@163.com, Ren, Huihui1,3 (AUTHOR) huizi9258@163.com, Yuan, Gang1,3 (AUTHOR) gangyuan@tjh.tjmu.edu.cn

    المصدر: Molecular Medicine. 9/4/2023, Vol. 29 Issue 1, p1-20. 20p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *TYPE 2 diabetes, *TAU proteins, *PHOSPHORYLATION, *COGNITION disorders

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.

    المؤلفون: Chan, Yi-Hsin1,2,3,4 (AUTHOR), Chao, Tze-Fan5,6 (AUTHOR), Chen, Shao-Wei2,7 (AUTHOR), Lee, Hsin-Fu2,8,9 (AUTHOR), Li, Pei-Ru10 (AUTHOR), Chen, Wei-Min10 (AUTHOR), Yeh, Yung-Hsin1,2 (AUTHOR), Kuo, Chi-Tai1,2 (AUTHOR), See, Lai-Chu10,11,12 (AUTHOR) lichu@mail.cgu.edu.tw, Lip, Gregory Y. H.13,14 (AUTHOR) gregory.lip@liverpool.ac.uk

    المصدر: Cardiovascular Diabetology. 6/28/2022, Vol. 21 Issue 1, p1-13. 13p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 agonists, *GLUCAGON-like peptide-1 receptor, *CD26 antigen, *TYPE 2 diabetes, *ATRIAL fibrillation, *HYPOGLYCEMIC agents

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.

    المؤلفون: Lorenz, Martin1 martin.lorenz@sanofi.com, Lawson, Francesca2, Owens, David3, Raccah, Denis4, Roy-Duval, Christine5, Lehmann, Anne6, Perfetti, Riccardo7, Blonde, Lawrence8

    المصدر: Cardiovascular Diabetology. 1/13/2017, Vol. 16, p1-10. 10p. 2 Charts, 5 Graphs.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *HEART beat, *EXENATIDE, *TYPE 2 diabetes, *NEURAL stimulation

    النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Highly glycosylated CD147 promotes hemorrhagic transformation after rt-PA treatment in diabetes: a novel therapeutic target?

    المؤلفون: Xie, Yanan1, Wang, Yingzhe1, Ding, Hongyan1, Guo, Min1, Wang, Xun1, Cui, Mei1, Dong, Qiang1,2,3

    المصدر: Journal of Neuroinflammation. 4/5/2019, Vol. 16 Issue 1, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *TISSUE plasminogen activator, *TREATMENT of diabetes, *GLUCAGON-like peptide-1 agonists, *TIGHT junctions, *BLOOD-brain barrier

    النص الكامل

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study.

    المؤلفون: Lugner, Moa1 (AUTHOR) Moa.lugner@gu.se, Sattar, Naveed2 (AUTHOR), Miftaraj, Mervete3 (AUTHOR), Ekelund, Jan3 (AUTHOR), Franzén, Stefan1,3 (AUTHOR), Svensson, Ann-Marie1,3 (AUTHOR), Eliasson, Björn1 (AUTHOR)

    المصدر: Cardiovascular Diabetology. 3/22/2021, Vol. 20 Issue 1, p1-11. 11p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 agonists, *SODIUM-glucose cotransporters, *TYPE 2 diabetes, *GLUCAGON-like peptide-1 receptor, *PERIPHERAL vascular diseases, *SCIENTIFIC observation, *DIABETES

    النص الكامل

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial.

    المؤلفون: Myat, Aung1,2 (AUTHOR) aung.myat@kcl.ac.uk, Redwood, Simon R.1 (AUTHOR), Arri, Satpal1 (AUTHOR), Gersh, Bernard J.3 (AUTHOR), Bhatt, Deepak L.4 (AUTHOR), Marber, Michael S.1 (AUTHOR)

    المصدر: Diabetology & Metabolic Syndrome. 2/12/2021, Vol. 13 Issue 1, p1-14. 14p.

    مصطلحات موضوعية: *EXERCISE tolerance, *LIRAGLUTIDE, *CROSSOVER trials, *GLUCAGON-like peptide-1 receptor, *HEMODYNAMICS, *TYPE 2 diabetes

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث